APA (7th ed.) Citation

Punglia, R. S., Burstein, H. J., Winer, E. P., & Weeks, J. C. (2008). Pharmacogenomic Variation of CYP2D6 and the Choice of Optimal Adjuvant Endocrine Therapy for Postmenopausal Breast Cancer: A Modeling Analysis. JNCI: Journal of the National Cancer Institute, 100(9), 642. https://doi.org/10.1093/jnci/djn100

Chicago Style (17th ed.) Citation

Punglia, Rinaa S., Harold J. Burstein, Eric P. Winer, and Jane C. Weeks. "Pharmacogenomic Variation of CYP2D6 and the Choice of Optimal Adjuvant Endocrine Therapy for Postmenopausal Breast Cancer: A Modeling Analysis." JNCI: Journal of the National Cancer Institute 100, no. 9 (2008): 642. https://doi.org/10.1093/jnci/djn100.

MLA (9th ed.) Citation

Punglia, Rinaa S., et al. "Pharmacogenomic Variation of CYP2D6 and the Choice of Optimal Adjuvant Endocrine Therapy for Postmenopausal Breast Cancer: A Modeling Analysis." JNCI: Journal of the National Cancer Institute, vol. 100, no. 9, 2008, p. 642, https://doi.org/10.1093/jnci/djn100.